苯拉唑马布
美波利祖马布
医学
白细胞介素5
单克隆
单克隆抗体
免疫学
哮喘
嗜酸性粒细胞
白细胞介素
抗体
细胞因子
作者
Arnaud Bourdin,Geoffrey Chupp,David J Jackson,David Cohen,Ulrika Emerath,Anat Shavit,Yulia Kurdyukova,Andrew Menzies‐Gow
标识
DOI:10.1016/j.jaip.2024.04.033
摘要
Benralizumab and mepolizumab are interleukin (IL)-5Rα/interleukin-5-targeted monoclonal antibodies indicated as add-on treatments for patients with uncontrolled severe eosinophilic asthma (SEA).
科研通智能强力驱动
Strongly Powered by AbleSci AI